Protective effect of fufanghuangqiduogan against acute liver injury in mice

World Journal of Gastroenterology

Volumn 11, Issue 19, 2005, Pages 2984-2989

  Gui, Shuang Ying ^a,b   Wei, Wei ^a   Wang, Hua ^a   Wu, Li ^a   Sun, Wu Yi ^a   Wu, Cheng Yi ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b ANHUI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Acute liver injury; Fufanghuangqiduogan; Radix Astragali; Radix Paeonia Pall

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ASTRAGALOSIDE; ASTRAGALUS EXTRACT; BCG VACCINE; BENZOYLPAEONIFLORIN; CARBON TETRACHLORIDE; CHINESE DRUG; EOSIN; FUFANGHUANGQIDUOGAN; GLUTATHIONE PEROXIDASE; GLYCYRRHIZA EXTRACT; HEMATOXYLIN; HERBACEOUS AGENT; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; LIVER PROTECTIVE AGENT; MALONALDEHYDE; OXYPAEONIFLORIN; PAEONIA LACTIFLORA EXTRACT; PAEONIFLORIN; PAEONIN; SCAVENGER; SOYASAPONIN I; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTRAGALUS PLANT; CELL MIGRATION; CHINESE MEDICINE; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG MECHANISM; DRUG RESPONSE; ENZYME ACTIVITY; ENZYME LOCALIZATION; IMMUNOLOGY; INFLAMMATORY CELL; LIVER HOMOGENATE; LIVER INJURY; LIVER NECROSIS; LIVER PROTECTION; MALE; MICROSCOPY; MOUSE; NONHUMAN; PROTEIN FUNCTION; RADIOIMMUNOASSAY; TISSUE DISTRIBUTION; TISSUE SECTION; TREATMENT OUTCOME; UPREGULATION;

EID: 20344374637     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i19.2984     Document Type: Article

References (34)

1. Dai LM, Chen XG, Xu SY. Protective effects of total glucosides of paeoney on experimental hepatitis. Zhongguo Yaolixue Tongbao 1993; 9: 449-453
2. Shen WM, Wang CB, Wang DQ, Tian YP, Yan GT, Hao XH. The protective effects of TFA on reperfusion induced hepatic injury in hemorrhagic shock. Zhongguo Yaolixue Tongbao 1997; 13: 532-534
3. Singh AK, Mani H, Seth P, Gaddipati JP, Kumari R, Banuadha KK, Sharma SC, Kulshreshtha DK, Maheshwari RK. Picroliv preconditioning protects the rat liver against ischemia-reperfusion injury. Eur J Pharmacol 2000; 395: 229-239
4. McKenna DJ, Jones K, Hughes K. Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications. Altern Ther Health Med 2001; 7: 70-86
5. Diamond BJ, Shiflett SC, Feiwel N, Matheis RJ, Noskin O, Richards JA, Schoenberger NE. Ginkgo biloba extract: mechanisms and clinical indications, Arch Phys Med Rehabil 2000; 81: 668-678
6. Hase K, Kasimu R, Basnet P, Kadota S, Namba T. Preventive effect of lithopermate B from Salvia miltiorhiza on experimental hepatitis by carbon tetrachloride or D-galactosanine/lipopolysaccharide. Planta Med 1997; 63: 22-26
7. Lin KJ, Chen JC, Tsauer W, Lin CC, Lin JG, Tsai CC. Prophylactic effect of four prescriptions of traditional Chinese medicine on a-naphthylisothiocyanate and carbon tetrachloride induced toxicity in rats. Acta Pharmacol Sin 2001; 22: 1159-1167
8. Mansour MA, Ginawi OT, El-Hadiyah T, El-Khatib AS, Al-Shabanah OA, Al-Sawaf HA. Effects of volatile oil constituents of Nigella sativa on carbon tetrachloride-induced hepatotoxicity in mice: evidence for antioxidant effects of thymoquinone. Res Commun Mol Pathol Pharmacol 2001; 110: 239-251
9. Santra A, Das S, Maity A, Rao SB, Mazumder DN. Prevention of carbon tetrachloride-induced hepatic injury in mice by Picrorhiza kurrooa. Indian J Gastroenterol 1998; 17: 6-9
10. Murakami T, Nagamura Y, Hirano K. The recovering effect of betaine on carbon tetrachloride-induced liver injury. J Nutr Sci Vitaminol 1998; 44: 249-255
11. Ferluga J. Tuberculin hypersensitivity hepatitis in mice infected with Mycobacterium bovis (BCG). Am J Pathol 1981; 105: 82-90
12. Yang Q, Lu JT, Zhou AW, Wang B, He GW, Chen MZ. Antinociceptive effect of astragalosides and its mechanism of action. Acta Pharmacol Sin 2001; 22: 809-812
13. Zhang YD, Shen JP, Zhu SH, Huang DK, Ding Y, Zhang XL. Effects of astragalus (ASI, SK) on experimental liver injury. Yaoxue Xuebao 1992; 27: 401-406
14. Li J, Tang XL, Chen MZ, Xu SY. Immunoregulatory mechanisms of total glucosides of paeoney in adjuvant arthritic rats. Zhongguo Yaolixue Tongbao 1995; 11: 475-478
15. Ge ZD, Wei W, Shen YX, Wang B, Ding CH, Zhou AW, Zhang AP, Xu SY. Effects of paeoniflorin, total glucosides of paeony removed paeoniflorin on interleukin 2 production by splenic lymphocytes form adjuvant arthritic rats. Anhui Yike Daxue Xuebao 1996; 31: 4-6
16. Gao BB, Dai LM, Xu SY. The scavenging activities of TGM and TGP on free radicals. Wuifang Yixueyuan Xuebao 1996; 18: 43-46
17. Xu DJ, Chen MZ. Effect of astragalus polysaccharide on immunologic function in mice. Anhui Yiyao 2003; 7: 418-419
18. Yu C, Wang F, Jin CL, Wu X, Chan WK, McKeehan WL. Increased carbon tetrachloride-induced liver injury and fibrosis in FGFR4-deficient nice. Am J Pathol 2002; 161: 2003-2010
19. Marucci L, Alpini G, Glaser SS, Alvaro D, Benedetti A, Francis H, Phinizy JL, Marzioni M, Mauldin J, Venter J, Baumann B, Ugili L, LeSege G. Taurocholate feeding prevents CCl4-induced damage of large cholangiocytes through PI3-kinase-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 2003; 284: G290-301
20. Marathe GK, Harrison KA, Roberts LJ2 2nd, Morrow JD, Murphy RC, Tjoelker LW, Prescott SM, Zimmerman GA, McIntyre TM. Identification of platelet-activating factor as the inflammatory lipid mediator in CCl4-metabolizing rat liver. J Lipid Res 2001; 42: 587-596
21. Terao J, Asano I, Matsushita S. High-performance liquid chromatographic determination of phospholipid peroxidation products of rat liver after carbon tetrachloride administration. Arch Biochem Biophys 1984; 235: 326-333
22. elSisi AE, Earnest DL, Sipes IG. Vitamin A potentiation of carbon tetrachloride hepatotoxicity: enhanced lipid peroxidation without enhanced biotransformation. Toxicol Appl Pharmacol 1993; 119: 289-294
23. elSisi AE, Earnest DL, Sipes IG. Vitamin A potentiation of carbon tetrachloride hepatotoxicity: role of liver macrophages and active oxygen species. Toxicol Appl Pharmacol 1993; 119: 295-301
24. Bruckner JV, Ramanathan R, Lee KM, Muralidhara S. Mechamisms of circadian rhythmicity of carbon tetrachloride hepatotoxicity. J Pharmacol Exp Ther 2002; 300: 273-281
25. Badger DA, Sauer JM, Hoglen NC, Jolley CS, Sipes IG. The role of inflammatory cells and cytochrome P450 in the potentiation of CCl4-induced liver injury by a single dose of retinol. Toxicol Appl Pharmacol 1996; 141: 507-519
26. Hsu CT. The role of the autonomic nervous system in chemically-induced liver damage and repair-using the essential hypertensive animal model (SHR). J Auton Nerv Syst 1995; 51: 135-142
27. Shands JW Jr, Senterfitt VC. Endotoxin-induced hepatic damage in BCG-infected mice. Am J Pathol 1972; 67: 23-30
28. Nagai H, Yakuo I, Yamada H, Shimazawa T, Koda A, Niu K, Asano K, Shimizu T, Kasahara M. Liver injury model in mice for immunopharmacological Study. Jpn J Pharmacol 1988; 46: 247-254
29. Streetz K, Leifeld L, Grundmann D, Ramakers J, Eckert K, Spengler U, Brenner D, Manns M, Trautwein C. Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology 2000; 119: 446-460
30. Crespo J, Cayon A, Fernandez-Gil P, Hernandez-Guerra M, Mayorga M, Dominguez-Diez A, Fernandez-Escalante JC, Pons-Romero F. Gene expression of tumor necrosis factor α and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology 2001; 34: 1158-1163
31. Colletti LM, Cortis A, Lukacs N, Kunkel SL, Green M, Strieter RM. Tumor necrosis factor up-regulates intercellular adhesion molecule 1, which is important in the neutrophil-dependent lung and liver injury associated with hepatic ischemia and repertusion in the rat. Shock 1998; 10: 182-191
32. Issekutz TB. Effects of six different cytokines on lymphocyte adherence to microvascular endothelium and in vivo lymphocyte migration in the rat. J Immunol 1990; 144: 2140-2146
33. Essani NA, McGuire GM, Manning AM, Jaeschke H. Endotoxin-induced act-ivation of the nuclear transcription factor κB and expression of E-selectin messenger RNA in hepatocytes, Kupffer cells, and endothelial cells in vivo. J Immunol 1996; 156: 2956-2963
34. Muto Y, Nouri-Aria KT, Meager A, Alexander GJ, Eddleston AL, Williams R. Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet 1988; 2: 72-74